Abũbuwan amfãni da rashin amfani da tursasawa masu tartsatsi
Kila ka ji cewa rumbun immunotherapy ko tsire-tsire na immunotherapy shine hanyar da za ta iya sarrafa lafiyar ka a cikin hanzari, tare da raguwar kwanan lokaci kai tsaye. Mene ne wadannan hanyoyin, menene amfanin da rashin amfani, kuma yaushe waɗannan hanyoyin da sukafi dacewa? Mene ne kake buƙatar tunani a kan yin hukunci mai kyau?
Immunotherapy for Allergies da Asthma
Immunotherapy , ko rashin lafiyar jiki, yana ba da magani kawai don rashin lafiyar rhinitis , rashin lafiyar conjunctivitis , ƙananan ƙwayoyin cuta , rashin ciwon fuka da rashin lafiya. Ba kamar magunguna ba ne kawai da ke rufe da rashin lafiyar cututtuka, alamar rashin lafiyar shine kawai farfado don canza yadda jikin mutum yake hulɗa da allergies. Don haka, za ku yi tunanin cewa kowa zai so ya yi kwakwalwa. Abin baƙin cikin shine, damuwa da rashin jin daɗi na iya zama mai wahala ga mutane da yawa saboda suna da wani babban lokaci (yawanci za su je gidan ofishin likitancin sau ɗaya a sau ɗaya a mako), kuma na iya ɗaukar watanni kafin su fara aiki.
Ƙararren hanzari (ƙarin) jadawalin wajibi ne wasu masu haɗari suke amfani da su don yin amfani da rashin lafiyar su don cimma matsayi mafi girma na rashin lafiyar jiki, wanda zai haifar da amfani da shagunan nan da nan. Wadannan jadawalin sun haifar da wani mutum yana samun "nauyin gudanarwa" sauri, da kuma iya shiga cikin ofishin mai ba da izini ba sau da yawa don shawo kan ƙwayar jiki lokacin da aka samu wannan nauyin tabbatarwa.
Akwai nau'i biyu na hanzarta gina-tsaren lokaci-rush immunotherapy da cluster immunotherapy.
Menene Rush Immunotherapy?
Rush immunotherapy ya hada da bada mutum yawan rashin jin dadi a kan wasu lokuta na tsawon sa'o'i zuwa kwanaki, da samun daidaituwa a cikin gajeren lokaci. Mafi sau da yawa, ana ba da allurai a kowace minti 15 zuwa 60 a tsawon lokaci zuwa kwana uku a farawa sannan kuma ya kara hanzari don samun maganin rigakafi.
Abũbuwan amfãni
Rush immunotherapy yana bawa mutane damar tashi zuwa maganin maganin rashin lafiyar su. Ana samun wannan a cikin makonni shida. Sabanin haka, tare da tarin daji na al'ada, mutane sukan karbi maganin daya sau ɗaya ko sau biyu a mako kuma zai iya daukar watanni uku zuwa wata shida don ginawa don maganin rigakafi. Bayan lokacin farko na rudirin immunotherapy, mutum zai iya shiga cikin ofishin likitancin sau ɗaya sau ɗaya a mako domin mako mai zuwa, to, har ma da sau da yawa.
Mutane da ke jurewa na rigakafi sunyi amfani da kariya daga rashin lafiyar jiki, yawanci a cikin 'yan makonni. Amfani tare da takaddama na rashin lafiyar jiki na iya ɗaukar lokaci mai tsawo, tare da amfani yawanci yana farawa a lokacin lokacin da aka samu takardun magani.
Rush immunotherapy ana amfani da shi ne ga mutanen da ke dauke da kwayar cututtukan nama (kudan zuma da ke ciwo da kwayar cutar ta jiki). Wannan yana ba da damar kare kariya daga cututtukan da ke cikin kwari, kuma zai iya kasancewa mafi aminci cikin hanyar magance mutanen da ke fama da ciwon daji. matsalar tare da rashin lafiyan halayen maganin rashin lafiyarsu. Wani bincike na shekara ta 2016 ya sami matashin immunotherapy don zama lafiya kuma mafi inganci ga ciwon hauka a yara.
A tsawon lokaci, rush immunotherapy zai iya zama mafi yawan kudin-tasiri.
Abubuwa mara kyau
Abin takaici, rush immunotherapy results a cikin rashin lafiyar halayen a cikin babban yawan mutane, don haka daban-daban magunguna (kamar antihistamines da corticosteroids ) ana ba da dama don hana ko rage girman wadannan halayen. Dole ne mutumin da ke yin gwagwarmaya ta rigakafi ya kasance yana shirye ya ciyar a kalla kwana biyu a cikin ofishin likitancin, yana karɓar nauyin tarin fuka da yawa a wannan lokaci.
Rush ya fi gaban lokaci, gaba daya yana shan cikakken yini ko fiye, yayin da yakan rage lokacin sadaukar da lokaci a kan.
Menene Cluster Immunotherapy?
Cluster immunotherapy da dama wani wuri tsakanin na al'ada immunotherapy da rush immunotherapy a kashi karuwa. Tare da rigakafin immunotherapy, sau da yawa sau biyu zuwa uku injections (na karba allurai) ana ba kowane ziyara. Ana tsammanin cewa tare da wannan fasaha, gyaran gyare-gyare na iya samuwa ta makonni hudu zuwa takwas (kwatankwacin watanni uku zuwa watanni shida). Yayin da yarinyar immunotherapy ya yi, wannan tsarin ya ba mutum damar samun ci gaba da tsayayyar hanzari amma yana dauke da halayen haɗari . Yawancin lokaci, ƙananan jigilar injections an buƙata gaba ɗaya fiye da daidaitattun tsarin immunotherapy
Layin Ƙasa
Rush da cluster immunotherapy bayar da wani madadin wa'adin gargajiya don rashin lafiyar shots, da damar mutum ya cimma mafi girma asurai na rashin lafiyar da sauri sauri, sabili da haka samun dama jima. Duk da haka, rush immunotherapy zai iya haifar da sakamako mai yawa na rashin lafiyan halayen. Rush yana da ƙari a gaban lokaci, yawanci shan cikakken yini ko fiye, yayin da zai iya zama mai tsaro lokaci daga baya.
Sau da yawa, mahaukaciyar hanyoyi suna da hanyoyi masu kyau na ba da cututtuka ga marasa lafiya, kuma suna da fifiko su samar da tsarin daidaitawa ga dukkan marasa lafiya. Yawancin masu yawan marasa lafiyar ba su ba marasa lafiya marasa zabi ba. Idan kuna sha'awar bin wadannan daga cikin wadannan hanyoyi masu tasowa, tuntuɓi masu yawan masu ciwo a yankinku don neman wanda yake da kwarewa a cikin waɗannan hanyoyi.
Sources:
Confino-Cohen, R., Rosman, Y., da kuma A. Goldberg. Rush Venom Immunotherapy a Yara. Journal of Allergy and Clinical Immunology. A Aiki . 2016 Nov 30. (Epub gaba da bugu).
Cox, L. Amfani da rashin amfani na Hanyar ƙaddamar da ƙwayar ƙwayoyin cutar. Jaridar Allergy da Clinical Immunology . 2008. 122 (2): 432-434.
Fan, Q., Liu, X., Gao, J., Huang, S., da L. Ni. Binciken kwatanta na Cluster tare da Immunotherapy na al'ada a cikin marasa lafiya tare da Rhinitis bala'in. Gwaji da magani mai warkewa . 2017. 13 (2): 717-722.
Perez-Rangel, I., Rogriguez Del Rio, P., Escudero, C., Sanchez Garcia, S., Sanchez-Hernandez, J. da kuma Ibanez. Ƙarfafawa da Tsaro na Rousse-Rousse-Rousin Immunotherapy a Cikakken Cizon Ƙari Mai Girma Yara: A Jarabawa na Gidan Gida. Annals na Allergy, Asthma da Immunology . 2017. 118 (3): 356-364.
Winslow, A., Turbyville, J., Sublett, JW., Sublett, JL. da S. Pollard. Daidaita Hanyoyin Sake Kayan Lafiya a Rush, Cluster, da Standard-Build Aeroallergen Immunotherapy. Annals na Allergy, Asthma, da Immunotherapy . 2016. 117 (5): 542-545.